Abstract. The gamma-ray detector of HETE-2, called FREGATE, has been designed to detect gamma-ray bursts in the energy range [6-400] keV. Its main task is to alert the other instruments of the occurrence of a gamma-ray burst (GRB) and to provide the spectral coverage of the GRB prompt emission in hard X-rays and soft gammarays. FREGATE was switched on on October 16, 2000, one week after the successful launch of HETE-2, and has been continuously working since then. We describe here the main characteristics of the instrument, its in-flight performance and we briefly discuss the first GRB observations.
We report on the development of an innovative CdTe detector plane (DPIX) optimized for the detection and localization of gamma-ray bursts in the X-ray band (below 100 keV). DPIX is part of an R&D program funded by the French Space Agency (CNES). DPIX builds upon the heritage of the ISGRI instrument, currently operating with great success on the ESA INTEGRAL mission. DPIX is an assembly of 200 elementary modules (XRDPIX) equipped with 32 CdTe Schottky detectors (4x4 mm2, 1 mm thickness) produced by ACRORAD Co. LTD. in Japan. These detectors offer good energy response up to 100 keV. Each XRDPIX is readout by the very low noise front-end electronics chip IDeF-X, currently under development at CEA/DSM/DAPNIA. In this paper, we describe the design of XRDPIX, the main features of the IDeF-X chip, and will present preliminary results of the reading out of one CdTe Schottky detector by the IDeF-X V1.0 chip. A low-energy threshold around 2.7 keV has been measured. This is to be compared with the 12-15 keV threshold of the ISGRI-INTEGRAL and BAT-SWIFT instruments, which both use similar detector material.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.